Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Pentoxifylline in Attenuating Neurological Disease Associated With HTLV-1 and Negative Modulator of Pathological Immune Response.

NCT01472263 is registered in ClinicalTrials.gov with Hospital Universitário Professor Edgard Santos as lead sponsor.

NCT NCT01472263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01472263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Pentoxifylline in Attenuating Neurological Disease Associated With HTLV-1 and Negative Modulator of Pathological Immune Response.
Lead sponsor
Hospital Universitário Professor Edgard Santos
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2009
Completion date
September 30, 2012
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

htlv-1, immune system diseases, pentoxifylline, physical disability, tropical spastic paraparesis